This content is excerpted from EyeNet’s MIPS 2023: A Primer and Reference; also see the Academy’s MIPS hub page.
Check your status. Use the QPP Participation Status Tool, where you can enter your 10-digit National Provider Identifier (NPI) to find out:
- if you are eligible to participate in MIPS;
- if any exclusions apply to you (and if so, whether you can opt in to MIPS); and
- if a special status—such as being in a small or rural practice—applies to you.
MIPS tip. If you are in multiple practices, make sure you scroll all the way down to check your status at each practice. For a step-by-step guide to using the QPP Participation Status Tool, download "2023 MIPS Eligibility and Participation Quick Start Guide" from the CMS QPP Resource Library.
Preliminary eligibility information published in late 2022. CMS uses two 12-month time segments (see “MIPS Determination Period,” below) to assess clinicians’ MIPS status. Since Jan.1, you could use the QPP Participation Status tool to see your preliminary eligibility information, based on data from the first time segment (Oct. 1, 2021-Sept. 30, 2022).
Final eligibility information published in November 2023. CMS will reconcile data from the second time segment (Oct. 1, 2022-Sept. 30, 2023) and will then update the tool with your final eligibility information. If you qualify for an exclusion based on data from one time segment, you will be exempt—even if you don’t qualify for the exclusion in the other time segment.
MIPS Determination Period
The MIPS determination period is a 24-month assessment period. It consists of two time segments; for the 2023 performance year, these are as follows:
- Oct. 1, 2021–Sept. 30, 2022 (with 30-day claims run out)
- Oct. 1, 2022–Sept. 30, 2023 (no claims run out)
Why the MIPS determination period matters. CMS uses data from these two time segments to determine whether clinicians fall under any of the low-volume thresholds and to see whether a practice should be assigned a special status, such as small practice or rural practice.
Previous: Who Does (and Doesn’t) Take Part in MIPS
Next: Low-Volume Clinicians Can Opt in to MIPS
DISCLAIMER AND LIMITATION OF LIABILITY: All information provided by the American Academy of Ophthalmology, its employees, agents, or representatives participating in the Academy’s efforts to explain regulatory and reimbursement issues is as current and reliable as reasonably possible. The Academy does not provide legal or accounting services or advice. You should seek legal and/or accounting advice if appropriate to your situation.
Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that either public or private payers will agree with the Academy’s information or recommendations.
The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from any such information provided by the Academy, its employees, agents, or representatives.
COPYRIGHT© 2023, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmology ®, American Academy of Ophthalmic Executives®, IRIS®, the Focus logo, and Protecting Sight. Empowering Lives ®, among other marks, are trademarks of the American Academy of Ophthalmology®.
All of the American Academy of Ophthalmology-developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).